Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions.

Literature DB >> 23051650

Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions.

Elena Maldi, Cristina Travelli, Antonio Caldarelli, Nicolò Agazzone, Sara Cintura, Ubaldina Galli, Maria Scatolini, Paola Ostano, Benedetta Miglino, Giovanna Chiorino, Renzo Boldorini, Armando A Genazzani.

Abstract

Entities: Disease Gene

Mesh：

Substances：

Year: 2012 PMID： 23051650 DOI： 10.1111/pcmr.12037

Source DB: PubMed Journal: Pigment Cell Melanoma Res ISSN： 1755-1471 Impact factor: 4.693

Keyword Cloud
Cited

× No keyword cloud information.

21 in total

Review 1. Immunomodulatory effects of sex hormones: requirements for pregnancy and relevance in melanoma.

Authors: Elizabeth Ann L Enninga; Shernan G Holtan; Douglas J Creedon; Roxana S Dronca; Wendy K Nevala; Simona Ognjanovic; Svetomir N Markovic
Journal: Mayo Clin Proc Date: 2014-04 Impact factor: 7.616

2. A nicotinamide phosphoribosyltransferase-GAPDH interaction sustains the stress-induced NMN/NAD⁺ salvage pathway in the nucleus.

Authors: Ambra A Grolla; Riccardo Miggiano; Daniele Di Marino; Michele Bianchi; Alessandro Gori; Giuseppe Orsomando; Federica Gaudino; Ubaldina Galli; Erika Del Grosso; Francesca Mazzola; Carlo Angeletti; Martina Guarneri; Simone Torretta; Marta Calabrò; Sara Boumya; Xiaorui Fan; Giorgia Colombo; Cristina Travelli; Francesca Rocchio; Eleonora Aronica; James A Wohlschlegel; Silvia Deaglio; Menico Rizzi; Armando A Genazzani; Silvia Garavaglia
Journal: J Biol Chem Date: 2020-01-27 Impact factor: 5.157

3. High visfatin expression predicts poor prognosis of upper tract urothelial carcinoma patients.

Authors: Hung-Lung Ke; Hui-Hui Lin; Wei-Ming Li; Ching-Chia Li; Lin-Li Chang; Yi-Chen Lee; Chun-Nung Huang; Wen-Jeng Wu
Journal: Am J Cancer Res Date: 2015-07-15 Impact factor: 6.166

Review 4. Nicotinamide phosphoribosyltransferase in malignancy: a review.

Authors: Rodney E Shackelford; Kim Mayhall; Nicole M Maxwell; Emad Kandil; Domenico Coppola
Journal: Genes Cancer Date: 2013-11

5. Selective targeting of NAMPT by KPT-9274 in acute myeloid leukemia.

Authors: Shaneice R Mitchell; Karilyn Larkin; Nicole R Grieselhuber; Tzung-Huei Lai; Matthew Cannon; Shelley Orwick; Pratibha Sharma; Yerdanose Asemelash; Pu Zhang; Virginia M Goettl; Larry Beaver; Alice Mims; Vinay K Puduvalli; James S Blachly; Amy Lehman; Bonnie Harrington; Sally Henderson; Justin T Breitbach; Katie E Williams; Shuai Dong; Erkan Baloglu; William Senapedis; Karl Kirschner; Deepa Sampath; Rosa Lapalombella; John C Byrd
Journal: Blood Adv Date: 2019-02-12

6. Increased Nicotinamide Phosphoribosyltransferase in Rhabdomyosarcomas and Leiomyosarcomas Compared to Skeletal and Smooth Muscle Tissue.

Authors: Moiz Vora; Junaid Ansari; Rabie M Shanti; Diana Veillon; James Cotelingam; Domenico Coppola; Rodney E Shackelford
Journal: Anticancer Res Date: 2016-02 Impact factor: 2.480

7. Proteomic identification of a marker signature for MAPKi resistance in melanoma.

Authors: Verena Paulitschke; Ossia Eichhoff; Christopher Gerner; Philipp Paulitschke; Andrea Bileck; Thomas Mohr; Phil F Cheng; Alexander Leitner; Emmanuella Guenova; Ieva Saulite; Sandra N Freiberger; Anja Irmisch; Bernhard Knapp; Nina Zila; Theodora-Pagona Chatziisaak; Jürgen Stephan; Joanna Mangana; Rainer Kunstfeld; Hubert Pehamberger; Ruedi Aebersold; Reinhard Dummer; Mitchell P Levesque
Journal: EMBO J Date: 2019-06-26 Impact factor: 11.598

Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions.

Review 1. Immunomodulatory effects of sex hormones: requirements for pregnancy and relevance in melanoma.

2. A nicotinamide phosphoribosyltransferase-GAPDH interaction sustains the stress-induced NMN/NAD⁺ salvage pathway in the nucleus.

3. High visfatin expression predicts poor prognosis of upper tract urothelial carcinoma patients.

Review 4. Nicotinamide phosphoribosyltransferase in malignancy: a review.

5. Selective targeting of NAMPT by KPT-9274 in acute myeloid leukemia.

6. Increased Nicotinamide Phosphoribosyltransferase in Rhabdomyosarcomas and Leiomyosarcomas Compared to Skeletal and Smooth Muscle Tissue.

7. Proteomic identification of a marker signature for MAPKi resistance in melanoma.

8. Expression of NAMPT is associated with breast invasive ductal carcinoma development and prognosis.

Review 9. Advances in NAD-Lowering Agents for Cancer Treatment.

Review 10. Metabolic Interplay between the Immune System and Melanoma Cells: Therapeutic Implications.

Nicotinamide phosphoribosyltransferase (NAMPT) is over-expressed in melanoma lesions.

Review 1. Immunomodulatory effects of sex hormones: requirements for pregnancy and relevance in melanoma.

2. A nicotinamide phosphoribosyltransferase-GAPDH interaction sustains the stress-induced NMN/NAD+ salvage pathway in the nucleus.

3. High visfatin expression predicts poor prognosis of upper tract urothelial carcinoma patients.

Review 4. Nicotinamide phosphoribosyltransferase in malignancy: a review.

5. Selective targeting of NAMPT by KPT-9274 in acute myeloid leukemia.

6. Increased Nicotinamide Phosphoribosyltransferase in Rhabdomyosarcomas and Leiomyosarcomas Compared to Skeletal and Smooth Muscle Tissue.

7. Proteomic identification of a marker signature for MAPKi resistance in melanoma.

8. Expression of NAMPT is associated with breast invasive ductal carcinoma development and prognosis.

Review 9. Advances in NAD-Lowering Agents for Cancer Treatment.

Review 10. Metabolic Interplay between the Immune System and Melanoma Cells: Therapeutic Implications.

2. A nicotinamide phosphoribosyltransferase-GAPDH interaction sustains the stress-induced NMN/NAD⁺ salvage pathway in the nucleus.